Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia

Bipolar Disorders

Volumn 16, Issue 8, 2014, Pages 790-799

  Chen, Chao ^a   Zhang, Chunling ^b   Cheng, Lijun ^c   Reilly, James L ^d   Bishop, Jeffrey R ^e   Sweeney, John A ^f   Chen, Hua Yun ^e   Gershon, Elliot S ^g   Liu, Chunyu ^a,e  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b University of Chicago   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g The University of Chicago   (United States)

Author keywords

Bipolar disorder; Butyrophilin, subfamily 3, member A3 (BTN3A3); CpG gene pairs (CGPs); DNA methylation; Gene expression; Nescient helix loop helix 1 (NHLH1); Phosphoinositide 3 kinase, regulatory subunit 1 (PIK3R1); Schizophrenia; Solute carrier family 16, member 7 (SLC16A7)

Indexed keywords

BUTYROPHILIN; DNA; MEMBRANE PROTEIN; MONOCARBOXYLATE TRANSPORTER 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BTN3A3; PROTEIN NHLH1; PROTEIN PIK3R1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BTN3A1 PROTEIN, HUMAN; BTNL9 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MONOCARBOXYLATE TRANSPORTER; NHLH1 PROTEIN, HUMAN; PIK3R1 PROTEIN, HUMAN; SLC16A7 PROTEIN, HUMAN;

ARTICLE; AUTOPSY; BASE PAIRING; BIPOLAR DISORDER; BTN3A3 GENE; CEREBELLUM; CONTROLLED STUDY; DNA METHYLATION; FRONTAL CORTEX; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NHLH1 GENE; PATHOGENESIS; PIK3R1 GENE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SLC16A7 GENE; CPG ISLAND; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; STATISTICS;

ANTIGENS, CD; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIPOLAR DISORDER; CEREBELLUM; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MONOCARBOXYLIC ACID TRANSPORTERS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATIDYLINOSITOL 3-KINASES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; STATISTICS AS TOPIC;

EID: 84913619766     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12255     Document Type: Article

References (46)

1. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33: 245-254.
2. Mill J, Tang T, Kaminsky Z et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 2008; 82: 696-711.
3. Iwamoto K, Bundo M, Yamada K et al. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 2005; 25: 5376-5381.
4. Grayson DR, Jia X, Chen Y et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA 2005; 102: 9341-9346.
5. Pidsley R, Mill J. Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry 2011; 69: 146-156.
6. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13: 484-492.
7. Gibbs JR, van der Brug MP, Hernandez DG et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 2010; 6: e1000952.
8. Sequeira PA, Martin MV, Vawter MP. The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis 2012; 45: 23-36.
9. Connor CM, Akbarian S. DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics 2008; 3: 55-58.
10. Impagnatiello F, Guidotti AR, Pesold C et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998; 95: 15718-15723.
11. Folsom TD, Fatemi SH. The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 2013; 68: 122-135.
12. Abdolmaleky HM, Cheng KH, Russo A et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005; 134B: 60-66.
13. Tamura Y, Kunugi H, Ohashi J, Hohjoh H. Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol Psychiatry 2007; 12: 593-600.
14. Kordi-Tamandani DM, Sahranavard R, Torkamanzehi A. Analysis of association between dopamine receptor genes' methylation and their expression profile with the risk of schizophrenia. Psychiatr Genet 2013; 23: 183-187.
15. Abdolmaleky HM, Cheng KH, Faraone SV et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 2006; 15: 3132-3145.
16. Abdolmaleky HM, Nohesara S, Ghadirivasfi M et al. DNA hypermethylation of serotonin transporter gene promoter in drug naive patients with schizophrenia. Schizophr Res 2014; 152: 373-380.
17. Kordi-Tamandani DM, Dahmardeh N, Torkamanzehi A. Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia. Gene 2013; 515: 163-166.
18. Konarski JZ, McIntyre RS, Grupp LA, Kennedy SH. Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? J Psychiatry Neurosci 2005; 30: 178-186.
19. Andreasen NC, Pierson R. The role of the cerebellum in schizophrenia. Biol Psychiatry 2008; 64: 81-88.
20. Schmitt A, Koschel J, Zink M et al. Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2010; 260: 101-111.
21. Smolin B, Karry R, Gal-Ben-Ari S, Ben-Shachar D. Differential expression of genes encoding neuronal ion-channel subunits in major depression, bipolar disorder and schizophrenia: implications for pathophysiology. Int J Neuropsychopharmacol 2012; 15: 869-882.
22. Chen C, Cheng L, Grennan K et al. Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry 2013; 18: 1308-1314.
23. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr Res 2000; 44: 151-155.
24. Bibikova M, Le J, Barnes B et al. Genome-wide DNA methylation profiling using Infinium (R) assay. Epigenomics 2009; 1: 177-200.
25. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8: 118-127.
26. Chen C, Grennan K, Badner J et al. Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods. PLoS ONE 2011; 6: e17238.
27. Narayan S, Tang B, Head SR et al. Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res 2008; 1239: 235-248.
28. Wockner LF, Noble EP, Lawford BR et al. Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl Psychiatry 2014; 4: e339.
29. Harris RA, Wang T, Coarfa C et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 2010; 28: 1097-1105.
30. Quon G, Lippert C, Heckerman D, Listgarten J. Patterns of methylation heritability in a genome-wide analysis of four brain regions. Nucleic Acids Res 2013; 41: 2095-2104.
31. Downey T. Analysis of a multifactor microarray study using Partek Genomics Solution. Methods Enzymol 2006; 411: 256-270.
32. Zhang D, Cheng L, Badner JA et al. Genetic control of individual differences in gene-specific methylation in human brain. Am J Hum Genet 2010; 86: 411-419.
33. Lee SH, Ripke S, Neale BM et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013; 45: 984-994.
34. Dennis G Jr, Sherman BT, Hosack DA et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4: P3.
35. Kainulainen V, Sundvall M, Maatta JA, Santiestevan E, Klagsbrun M, Elenius K. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis. J Biol Chem 2000; 275: 8641-8649.
36. Krivosheya D, Tapia L, Levinson JN et al. ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms. J Biol Chem 2008; 283: 32944-32956.
37. Bowden NA, Scott RJ, Tooney PA. Altered gene expression in the superior temporal gyrus in schizophrenia. BMC Genomics 2008; 9: 199.
38. Law AJ, Wang YH, Sei Y et al. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110 delta inhibition as a potential therapeutic strategy. Proc Natl Acad Sci USA 2012; 109: 12165-12170.
39. Shi JX, Levinson DF, Duan JB et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753-757.
40. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
41. Lipkowitz S, Gobel V, Varterasian ML, Nakahara K, Tchorz K, Kirsch IR. A comparative structural characterization of the human NSCL-1 and NSCL-2 genes. Two basic helix-loop-helix genes expressed in the developing nervous system. J Biol Chem 1992; 267: 21065-21071.
42. Halestrap AP. The SLC16 gene family - structure, role and regulation in health and disease. Mol Aspects Med 2013; 34: 337-349.
43. Liu Y, Li Z, Zhang M, Deng Y, Yi Z, Shi T. Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis. BMC Med Genomics 2013; 6 (Suppl. 1): S17.
44. Brown L, Espinosa R 3rd, Le Beau MM, Siciliano MJ, Baer R. HEN1 and HEN2: a subgroup of basic helix-loop-helix genes that are coexpressed in a human neuroblastoma. Proc Natl Acad Sci USA 1992; 89: 8492-8496.
45. McDermott E, de Silva P. Impaired neuronal glucose uptake in pathogenesis of schizophrenia - can GLUT 1 and GLUT 3 deficits explain imaging, post-mortem and pharmacological findings? Med Hypotheses 2005; 65: 1076-1081.
46. Melka MG, Laufer BI, McDonald P et al. The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum. Clin Epigenetics 2014; 6: 1.